Using Retained Earnings for Capital Expenditures and R&D Investment
First written in FY2016. 5 of 9 entries say "Restated". Latest entry: 2026-05-20.
Shin-Etsu Chemical moved to the "Worse" side of this theme in 2020, 6 years before the typical company in this theme (2026).
51 other companies' latest entry also says "Restated".
- FY2025ReframedAnnual report
「Our basic policy is to focus on expanding business earnings and maintaining financial discipline, and to return the results of our management efforts to shareholders in an appropriate and stable manner. Retained earnings are used actively and in a timely manner, alongside efforts to strengthen competitiveness, to support future business development and further growth, with the aim of increasing corporate value. In addition, while maintaining the financial foundation needed to withstand increasingly frequent and volatile economic fluctuations, we are pursuing capital policies with due attention to return on equity and the cost of capital.」
The previous policy of using retained earnings to strengthen competitiveness and fund growth investment while maintaining a financial foundation has been supplemented by capital policies focused on financial discipline, ROE and the cost of capital. - FY2022RestatedAnnual report
「Retained earnings are used actively and in a timely manner, alongside efforts to strengthen competitiveness, to support future business development and further growth, with the aim of increasing corporate value. In addition, the company will maintain the financial foundation needed to withstand increasingly frequent and volatile economic fluctuations.」
The company continues its policy of using retained earnings for growth investment and strengthening competitiveness, while maintaining a financial foundation to prepare for economic fluctuations. - FY2021ReframedAnnual report
「Retained earnings are allocated in a timely manner to capital investment, R&D investment, acquisitions and other purposes, and are actively used alongside efforts to strengthen competitiveness to support future business development and further growth, with the aim of increasing corporate value. To withstand the ongoing infectious disease crisis and major economic fluctuations that may arise, the company will maintain the financial foundation needed to support its operations.」
Acquisitions have been explicitly added to the uses of retained earnings, alongside growth investment through capital and R&D investment and the maintenance of a financial foundation to prepare for the infectious disease crisis and economic fluctuations. - FY2020ReframedAnnual report
「Retained earnings are allocated in a timely manner to capital investment, R&D investment, acquisitions and other purposes, and are actively used to strengthen competitiveness, support future business development and further growth, with the aim of increasing corporate value. In light of the COVID-19 pandemic currently facing the world, the company will maintain the financial foundation needed to withstand major economic fluctuations that may arise.」
The previous policy of using retained earnings for capital investment and R&D investment has been supplemented by maintaining a financial foundation to prepare for the COVID-19 pandemic and major economic fluctuations. - FY2018RestatedAnnual report
「Retained earnings are allocated to capital investment, R&D investment and other purposes, and are actively used to strengthen international competitiveness and support future business development, with the aim of increasing corporate value.」
The company reiterates its policy of using retained earnings for capital investment, R&D investment and business development. - FY2017RestatedAnnual report
「Retained earnings are allocated to capital investment, R&D investment and other purposes, and are actively used to strengthen international competitiveness and support future business development, with the aim of increasing corporate value.」
The company reiterates its policy of using retained earnings for capital investment, R&D investment and business development. - FY2016First statedAnnual report
「Retained earnings are allocated to capital investment, R&D investment and other purposes, and are actively used to strengthen international competitiveness and support future business development, with the aim of increasing corporate value.」
The company states its policy of allocating retained profits to capital investment, R&D investment and business development.